Avidity Biosciences, Inc. Alternatives & Competitors
12 companies similar to Avidity Biosciences, Inc. — At Avidity, we are developing a new class of oligonucleotide-based therapies.
Companies similar to Avidity Biosciences, Inc.
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
Ractigen Therapeutics
Turn on genes and turn off diseases
Suzhou, China
AIRNA
The next generation of RNA editing therapeutics
Cambridge, United States
Ultragenyx
Going Beyond Every Day
Novato, United States
Rival Readout
Competing with Avidity Biosciences, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Dianthus Therapeutics, Inc.
Building a leading biotech company focused in severe autoimmune diseases.
United States
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
Cardior Pharmaceuticals
Cardior develops RNA-based therapeutics designed to prevent, repair and reverse diseases o...
Germany
HepaRegeniX GmbH
Unlocking liver regeneration - delivering recovery
Tubingen, Germany
ADARx Pharmaceuticals Inc.
Our vision is to provide effective and safe RNA therapeutics to patients who suffer from i...
San Diego, United States
Bluejay Therapeutics
Developing innovative cures for infectious diseases with the first target indication of ch...
United States
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
Adcentrx Therapeutics
Merging Chemistry and Biology to Benefit the Lives of Patients
San Diego, United States
About Avidity Biosciences, Inc.
Avidity Biosciences, Inc., founded in 2013, operates from its headquarters in the United States and is rapidly carving out a significant niche within the Biotechnology, Health Care, Health and Wellness, Life Sciences, and Pharmaceutical industries. Avidity is noted for its slogan, "At Avidity, we are developing a new c...
AOC Platform Development, Clinical Research for Muscle Diseases, Rare Disease Therapeutic Solutions, Pipeline Expansion
Patients with Rare Muscle Diseases, Healthcare Professionals, Medical Researchers, Investors in Biopharmaceuticals
Oligonucleotide-based Therapies, RNA Therapeutics, AOC Platform, Monoclonal Antibodies, Genetic Drivers Of Diseases, Precision Medicine, Therapeutic Development, Medical Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Avidity Biosciences, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Avidity Biosciences, Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 27 Nov 2025 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
